(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
New movies to watch this week: See 'Marty Supreme' in theaters, rent 'Springsteen: Deliver Me from Nowhere,' stream 'Cover-Up' on Netflix - 2Israeli archaeologists launch project to trace origins of ancient pottery
- 3More than half way to the moon, the Artemis II astronauts are grappling with a toilet problem
- 4Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
- 5Radiated Tortoise Faces Rapid Decline in Madagascar
- The 10 Most Persuasive Forerunners in Innovation
- Step by step instructions to Guarantee Your Internet Promoting Degree Supplements Your Profession Objectives
- Spanish bishops and government sign deal for compensation of church sexual abuse victims
- Internet goes (cocoa) nuts: The funniest reactions to 12 tonne theft of KitKat bars
- Iranian-linked drone attack kills Kurdish couple in northern Iraq
- Audits of 6 Specialty Mixed drinks
- The Way to Monetary Health: Individual budget Change
- Hezbollah claims right to respond to killing of top commander
- Online business Stages for Little Retailers
